{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:37:30Z","timestamp":1760315850036,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Hyogo College of Medicine, 2011"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jjcc.2013.08.004","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T10:49:24Z","timestamp":1379760564000},"page":"205-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients"],"prefix":"10.1016","volume":"63","author":[{"given":"Mitsuru","family":"Masaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Komamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Hirotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misato","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Nakabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Lee-Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Koshiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2013.08.004_bib0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0025-7125(03)00168-8","article-title":"Cardiac remodeling in systemic hypertension","volume":"88","author":"Kenchaiah","year":"2004","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jjcc.2012.12.015","article-title":"Effect of epicardial adipose tissue on diastolic functions and left atrial dimension in untreated hypertensive patients with normal systolic function","volume":"61","author":"Cetin","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling \u2013 concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jjcc.2012.12.004","article-title":"Efficacy and safety of a 60-week treatment with candesartan in Japanese patients with mild to moderate chronic heart failure","volume":"61","author":"Matsuzaki","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.HYP.0000254322.96189.85","article-title":"Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial","volume":"49","author":"Gerdts","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0030","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.amjcard.2005.09.143","article-title":"Effects of quinapril on left atrial structural remodeling and arterial stiffness","volume":"97","author":"Tsang","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0035","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1046\/j.1523-1755.2000.00973.x","article-title":"Cardiac aldosterone production and ventricular remodeling","volume":"57","author":"Delcayre","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/HJH.0b013e32834103d4","article-title":"Role of plasma aldosterone concentration in regression of left-ventricular mass following antihypertensive medication","volume":"29","author":"Yoshida","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/01.CIR.92.4.835","article-title":"Left atrial size and the risk of stroke and death. The Framingham Heart Study","volume":"92","author":"Benjamin","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4065\/76.5.467","article-title":"Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women","volume":"76","author":"Tsang","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.HYP.0000052830.02773.E4","article-title":"Atrial fibrillation in hypertension: predictors and outcome","volume":"41","author":"Verdecchia","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0060","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/archinte.165.15.1788","article-title":"Left atrium size and the risk of cardiovascular death in middle-aged men","volume":"165","author":"Laukkanen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jjcc.2013.03.003","article-title":"Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation","volume":"62","author":"Nishino","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0075","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.amjcard.2005.05.031","article-title":"Usefulness of left atrial volume in predicting first congestive heart failure in patients > or =65 years of age with well-preserved left ventricular systolic function","volume":"96","author":"Takemoto","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2005.07.126","article-title":"Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons > or =65 years of age (the cardiovascular health study)","volume":"97","author":"Gottdiener","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0090","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","article-title":"Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction","volume":"124","author":"Zile","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0095","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.89.2.724","article-title":"Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study","volume":"89","author":"Vaziri","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jacc.2004.09.054","article-title":"Diastolic dysfunction and left atrial volume: a population-based study","volume":"45","author":"Pritchett","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0105","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0110","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11886-012-0268-8","article-title":"Left atrial volume: clinical value revisited","volume":"14","author":"Tsang","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0115","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0735-1097(03)00956-2","article-title":"The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk","volume":"42","author":"Douglas","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2009.07.059","article-title":"The hypertensive heart. An integrated understanding informed by imaging","volume":"55","author":"Raman","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJMp048132","article-title":"Aldosterone\u2013villain or bystander?","volume":"351","author":"Dluhy","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0130","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00004872-200106000-00023","article-title":"Regression of left ventricular hypertrophy in human hypertension with irbesartan","volume":"19","author":"Malmqvist","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0135","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1097\/HJH.0b013e3282170ada","article-title":"Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)","volume":"25","author":"Muller-Brunotte","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/db06-1163","article-title":"Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.0000168046.19884.6a","article-title":"PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin","volume":"46","author":"Clasen","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","article-title":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice","volume":"75","author":"Oudit","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0155","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0735-1097(03)00464-9","article-title":"Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation","volume":"41","author":"Kumagai","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jjcc.2011.06.003","article-title":"Angiotensin II type 1 receptor blocker attenuates diabetes-induced atrial structural remodeling","volume":"58","author":"Kato","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0165","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0895-7061(01)02218-X","article-title":"The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study","volume":"14","author":"Lefrandt","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0170","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00004872-200206000-00026","article-title":"Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects","volume":"20","author":"Struck","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0175","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1476-5381.2009.00407.x","article-title":"Long-term blockade of L\/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart","volume":"158","author":"Takahara","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0735-1097(93)90735-J","article-title":"Failure of calcium channel blockers to improve ventricular relaxation in humans","volume":"21","author":"Nishimura","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jjcc.2012.02.011","article-title":"Factors influencing left atrial volume in treated hypertension","volume":"60","author":"Chen","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0190","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0200","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/HJH.0b013e3282f35c67","article-title":"Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial","volume":"26","author":"Schmieder","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.jjcc.2013.08.004_bib0205","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by renin\u2013angiotensin system inhibition a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508713002414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508713002414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:52:24Z","timestamp":1760273544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508713002414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0914508713002414"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2013.08.004","relation":{},"ISSN":["0914-5087"],"issn-type":[{"type":"print","value":"0914-5087"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of irbesartan on plasma aldosterone concentration and left atrial volume in hypertensive patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2013.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}